MedPath

Treatment of Fat deposition in liver by a Unani Formulation.

Phase 2
Conditions
Health Condition 1: null- Non-Alcoholic fatty Liver Disease
Registration Number
CTRI/2018/01/011531
Lead Sponsor
ational Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of either gender

2. Age group of 18-60 years

3. Diagnosed cases of fatty liver (Grade I and Grade II) by ultrasonogram

4. Patients with/ without clinical signs and symptoms like Anorexia, Nausea, Dyspepsia, Fatigue, Dull ache/ Heaviness in right hypochondriac region and Hepatomegaly.

5. Nonalcoholic patients

Exclusion Criteria

1. Pregnant and lactating women

2. Fatty liver Grade III

3. Positive Hepatitis markers

4. Patients suffering from systemic and metabolic diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in grade of Fatty Liver as per UltrasonogramTimepoint: before treatment and After treatment
Secondary Outcome Measures
NameTimeMethod
Improvement in Quality of life.Timepoint: Before treatment and After treatment
© Copyright 2025. All Rights Reserved by MedPath